TG6002 oncolytic vaccinia virus and chemotherapy synergy: a promising strategy for pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant cancer characterized by poor prognosis and limited treatment options, often associated with significant toxicity. Recently, we described TG6002, an oncolytic vaccinia virus (VACV) engineered for tumor-selective replication through the del...
Gardado en:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2025-09-01
|
| Series: | Frontiers in Microbiology |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1656984/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|